Maryam Khazraee

Affiliations

Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Publications (1)

Benefit-Risk Summary of Nivolumab for the Treatment of Patients with Unresectable Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma After Prior Fluoropyrimidine- and Platinum-Based Chemotherapy.

The oncologist

Avec: Lorraine Pelosof , May Tun Saung , Martha Donoghue , Sandra Casak , Sirisha Mushti , Joyce Cheng , Xiling Jiang , Jiang Liu , Hong Zhao , Maryam Khazraee , Kirsten B Goldberg , Marc Theoret , Steven Lemery , Richard Pazdur , Lola Fashoyin-Aje

Réseau de co-auteurs

Lorraine Pelosof 1 collaboration

May Tun Saung 1 collaboration

Martha Donoghue 1 collaboration

Sandra Casak 1 collaboration

Sirisha Mushti 1 collaboration

Joyce Cheng 1 collaboration

Xiling Jiang 1 collaboration

Jiang Liu 1 collaboration

Hong Zhao 1 collaboration

Kirsten B Goldberg 1 collaboration

Marc Theoret 1 collaboration

Steven Lemery 1 collaboration

Richard Pazdur 1 collaboration

Lola Fashoyin-Aje 1 collaboration